10
DEC
2015

Highlights From ASH 2015: Data Presented From 3 Phase 2 Trials Evaluating Blinatumomab (Blincyto®) in Adults With Acute Lymphoblastic Leukemia

Although rare, acute lymphoblastic leukemia (ALL) is a rapidly progressing cancer of the blood and bone marrow. No broadly accepted standard treatment regimen currently exists for adults with relapsed or refractory ALL beyond chemotherapy, and the overall median survival for...
10
DEC
2015

Idarucizumab (Praxbind®) Reverses Anticoagulant Effects of Dibigatran (Pradaxa®)

Idarucizumab (Praxbind®) is a fully humanized monoclonal antibody fragment, or Fab, with high binding affinity for the oral direct thrombin inhibitor dabigatran (Pradaxa®) that selectively and immediately neutralizes its anticoagulant activity. Idarucizumab is approved for the...
10
DEC
2015

Panobinostat (Farydak®) Is Effective for Patients With Relapsed Multiple Myeloma

Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasma cells in the bone marrow. MM mainly affects older adults. In 2014, an estimated 24,050 new cases of MM were diagnosed, and an estimated 11,090 deaths occurred from MM. The...
07
DEC
2015

Connexion Healthcare Attends NCCN Patient Advocacy Summit

Panelists for the session on Cost of Cancer Care and the Patient Impact. Panelists from left to right:  Dan Klein, Patient Access Network Foundation; Susan Pelletier, Cancer Survivor and Advocate; Len Saltz, MD, Memorial Sloan Kettering Cancer Center; Veena Shankaran, MD, MS,...
01
DEC
2015

Connexion Healthcare CEO Appointed to Board of Directors of NCCN Foundation

Newtown, PA – November 24, 2015 – Susan C. Stein, MPH, CEO and Founder of the award-winning Connexion Healthcare, has been appointed to the Board of Directors of the National Comprehensive Cancer Network® (NCCN) Foundation along with Heather Kopecky, PhD, MBA, and Marc Samuels,...
13
NOV
2015

November Is Pancreatic Cancer Awareness Month: Join the Movement to End This Deadly Disease

Pancreatic cancer is one of the deadliest of all cancers. It responds poorly to treatment and spreads quickly to surrounding organs. When it comes to pancreatic cancer: It is the 7th most common cause of death worldwide. It is the 4th leading cause of death in the United States....
10
NOV
2015

November is Carcinoid / Neuroendocrine Tumor (NET) Cancer Awareness Month

You have probably never heard of these small, slow-growing cancers. Although rare, carcinoid/neuroendocrine cancers are diagnosed in more than 12,000 Americans every year and approximately 125,000 Americans are living with carcinoid/NET cancer today. These tumors usually develop...
23
OCT
2015

Support Alex’s Lemonade Stand Foundation’s Tenth Annual Lemon Ball ― A Great Event, A Great Cause!

Hear from this year’s co-chairs of the Annual Lemon Ball, Susan Stein, MPH, Founder and CEO of Connexion Healthcare, and Robert Stein, Esquire, CFO/COO, who are dedicated to improving the futures of children with cancer. If you are interested in becoming a sponsor, please contact...
21
OCT
2015

Connexion Healthcare attends NORD Rare Summit 2015

Promoting Earlier Diagnosis Through Physician Education and Awareness.  Our Profession and our Passion at Connexion Healthcare
20
OCT
2015

Get in the Pink: October is National Breast Cancer Awareness Month

Get your Connexion Healthcare Breast Cancer Awareness infographic and boost your knowledge. Click on the image below to download your complimentary copy.